News

  •

    Juan Song, PhD, receives Hettleman Prize

    Juan Song, PhD, assistant professor of pharmacology and member of the UNC Neuroscience Center, was one of four professors from UNC-Chapel Hill to be awarded the Phillip and Ruth Hettleman Prizes for Artistic and Scholarly Achievement by Young Faculty. Dr. Song came to Carolina in fall 2013 and leads a research team trying to understand … Continued

  •

    Hyejung Won, PhD, Receives 2018 NARSAD Young Investigator Grant

    The Brain & Behavior Research Foundation announced the awarding of its Young Investigator Grants valued at more than $13.8 million to 200 of the world’s most promising young scientists. The grants, awarded annually, support the work of early-career scientists with innovative ideas for groundbreaking neurobiological research seeking to identify causes, improve treatments and develop prevention … Continued

  •

    19th Annual Andrew S. Rachlin Symposium

      The 19th Annual UNC Neuroscience Symposium will be held on Thursday, October 11th at the Carolina Club. The annual Andrew S Rachlin UNC Neuroscience Symposium will be held on October 11th, 2018 at the Carolina Club (150 Stadium Dr, Chapel Hill, NC 27514). This year’s Symposium will focus on genetic variation associated with neuropsychiatric … Continued

  •

    Song Lab Publishes in Neuron

    UNC School of Medicine neuroscientist Juan Song, PhD, and colleagues show how specific brain cells communicate with adult neural stem cells, a discovery that could open new investigations into potential treatments for some neurological disorders and brain injuries. A small population of brain cells deep in a memory-making region of the brain controls the production … Continued

  •

    Zylka Lab Awarded Angelman Sydrome Foundation Grant

    Angelman Syndrome is a severe neurodevelopmental disorder that is caused by loss of the maternal copy of the Ube3a gene. Using the gene editing technology CRISPR/Cas9, a team of scientists in the Zylka lab was able to correct the underlying molecular deficiency in the Angelman mouse model. The Zylka Lab was awarded a grant from the Angelman Syndrome Foundation to expand this finding towards a gene therapy.